Universal-Beteiligungs- und Servicegesellschaft’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$102M Sell
1,682,461
-155,360
-8% -$9.06M 0.18% 108
2025
Q4
$99.7M Buy
1,837,821
+95,242
+5% +$4.58M 0.16% 108
2025
Q3
$78.6M Buy
1,742,579
+70,320
+4% +$3.28M 0.13% 139
2025
Q2
$77.4M Buy
1,672,259
+107,540
+7% +$5.28M 0.14% 146
2025
Q1
$95.4M Sell
1,564,719
-199,395
-11% -$11.6M 0.19% 113
2024
Q4
$99.8M Buy
+1,764,114
New +$98.6M 0.2% 104

Other funds holding BMY

Universal-Beteiligungs- und Servicegesellschaft's BMY Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Bristol-Myers Squibb (BMY) stake by 8.5% in Q1 2026, selling an estimated $9.06M and leaving 1,682,461 shares worth $102M. The position accounts for 0.18% of the portfolio, ranked #108.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 1,682,461 shares of Bristol-Myers Squibb worth $102M as of Q1 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 155,360 Bristol-Myers Squibb shares in Q1 2026, an estimated $9.06M.
  • Bristol-Myers Squibb made up 0.18% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q1 2026, its #108 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.